Permanent Atrial Fibrillation
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
63%
5 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial
Clinical Efficacy of Left Bundle Branch Area Pacing for Patients With Permanent Atrial Fibrillation and Heart Failure
Rate Control in Atrial Fibrillation II
Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study